BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1951308)

  • 1. Occupational risk for hematological malignancies.
    Pasqualetti P; Casale R; Colantonio D; Collacciani A
    Am J Hematol; 1991 Oct; 38(2):147-9. PubMed ID: 1951308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An Italian multicenter case-control study on malignant neoplasms of the hematolymphopoietic system. Hypothesis and preliminary results on work-related risks. WILL (Working Group on Hematolymphopoietic Malignancies in Italy)].
    Costantini AS; Miligi L; Vineis P
    Med Lav; 1998; 89(2):164-76. PubMed ID: 9673106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative and myeloproliferative disease in Tasmania.
    Lickiss JN; Baikie AG; Panton J
    Natl Cancer Inst Monogr; 1977 Dec; 47():37-9. PubMed ID: 613244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic malignancies and related disorders among benzene-exposed workers in China.
    Travis LB; Li CY; Zhang ZN; Li DG; Yin SN; Chow WH; Li GL; Dosemeci M; Blot W; Fraumeni JF
    Leuk Lymphoma; 1994 Jun; 14(1-2):91-102. PubMed ID: 7920231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational Risk Factors of Lymphohematopoietic Cancer in Rayong Province, Thailand.
    Punjindasup A; Sangrajrang S; Ekpanyaskul C
    J Med Assoc Thai; 2015 Nov; 98 Suppl 10():S13-22. PubMed ID: 27276828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nationwide survey of co-occurrence of malignant lymphomas and myelodysplastic syndromes/myeloproliferative neoplasms.
    Sakata-Yanagimoto M; Yokoyama Y; Muto H; Obara N; Kurita N; Kato T; Hasegawa Y; Miyazaki Y; Kurokawa M; Chiba S
    Ann Hematol; 2016 Apr; 95(5):829-30. PubMed ID: 26891876
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of monoclonal gammopathy of undetermined significance: a case-referent study.
    Pasqualetti P; Collacciani A; Casale R
    Am J Hematol; 1996 Jul; 52(3):217-20. PubMed ID: 8756092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematological, myelotoxic, clastogenic, carcinogenic, and leukemogenic effects of benzene.
    van Raalte HG; Grasso P
    Regul Toxicol Pharmacol; 1982 Jun; 2(2):153-76. PubMed ID: 6764552
    [No Abstract]   [Full Text] [Related]  

  • 9. [Practice of recognizing benzene-caused occupational diseases in 2006].
    Beelte S; Haas R; Germing U; Jansing PJ
    Med Klin (Munich); 2008 Aug; 103(8):553-60. PubMed ID: 18807229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to non-arsenic pesticides is associated with lymphoma among farmers in Spain.
    van Balen E; Font R; Cavallé N; Font L; Garcia-Villanueva M; Benavente Y; Brennan P; de Sanjose S
    Occup Environ Med; 2006 Oct; 63(10):663-8. PubMed ID: 16757510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease.
    Goldberg H; Lusk E; Moore J; Nowell PC; Besa EC
    Cancer Res; 1990 Nov; 50(21):6876-81. PubMed ID: 2208156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian multicentre case-control study of hematolymphopoietic malignancies.
    Vineis P; Seniori Costantini A
    Med Lav; 1990; 81(6):506-12. PubMed ID: 2100766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational exposure to polycyclic aromatic hydrocarbons and lymphatic and hematopoietic neoplasms: a systematic review and meta-analysis of cohort studies.
    Alicandro G; Rota M; Boffetta P; La Vecchia C
    Arch Toxicol; 2016 Nov; 90(11):2643-2656. PubMed ID: 27530719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex ratios and the risks of haematological malignancies.
    Cartwright RA; Gurney KA; Moorman AV
    Br J Haematol; 2002 Sep; 118(4):1071-7. PubMed ID: 12199787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good, the bad, and the ugly.
    Allen JR; Wright RL; Johnson PJ
    Occup Health Saf; 2013 Sep; 82(9):26-8. PubMed ID: 24260938
    [No Abstract]   [Full Text] [Related]  

  • 17. Occupation and malignant lymphoma: a population based case control study in Germany.
    Mester B; Nieters A; Deeg E; Elsner G; Becker N; Seidler A
    Occup Environ Med; 2006 Jan; 63(1):17-26. PubMed ID: 16361401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational exposure to solvents and the risk of lymphomas.
    Miligi L; Costantini AS; Benvenuti A; Kriebel D; Bolejack V; Tumino R; Ramazzotti V; Rodella S; Stagnaro E; Crosignani P; Amadori D; Mirabelli D; Sommani L; Belletti I; Troschel L; Romeo L; Miceli G; Tozzi GA; Mendico I; Vineis P
    Epidemiology; 2006 Sep; 17(5):552-61. PubMed ID: 16878041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hair dyes and lymphoid neoplasms: an update.
    La Vecchia C; Tavani A
    Eur J Cancer Prev; 2002 Oct; 11(5):409-12. PubMed ID: 12394236
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.